UBS Group AG - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$10,000
-16.7%
54,695
+81.0%
0.00%
Q4 2021$12,000
-20.0%
30,211
+85.3%
0.00%
Q3 2021$15,000
+1400.0%
16,306
+1595.0%
0.00%
Q2 2021$1,000
-97.9%
962
-97.4%
0.00%
Q1 2021$47,000
+147.4%
36,976
+269.6%
0.00%
Q4 2020$19,000
-66.7%
10,005
-55.7%
0.00%
Q3 2020$57,000
+39.0%
22,596
+21.2%
0.00%
Q2 2020$41,000
+215.4%
18,643
+252.6%
0.00%
Q1 2020$13,000
+160.0%
5,287
+196.0%
0.00%
Q4 2019$5,000
-28.6%
1,786
-62.3%
0.00%
Q3 2019$7,000
-41.7%
4,735
+7.3%
0.00%
Q2 2019$12,0000.0%4,411
-23.8%
0.00%
Q1 2019$12,000
+300.0%
5,789
+183.9%
0.00%
Q4 2018$3,000
-66.7%
2,039
-48.7%
0.00%
Q2 2018$9,000
+125.0%
3,975
+67.4%
0.00%
Q1 2018$4,0002,3750.00%
Other shareholders

There were no reported owners of SOLENO THERAPEUTICS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of SOLENO THERAPEUTICS INC shareholders